We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CPHGF market cap is 847.23M. The company's latest EPS is CNY 0.9662 and P/E is 1.08.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 1.73B | 1.75B | 2.04B | 2.34B | 2.59B |
| Operating Income | 171.56M | 584.27M | 642.14M | 687.79M | 813.33M |
| Net Income | 79.82M | 498.79M | 590.17M | 682.91M | 784.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 3.71B | 3.95B | 4.36B | 4.89B | 5.51B |
| Total Liabilities | 1.4B | 1.43B | 1.45B | 1.45B | 1.59B |
| Total Equity | 2.31B | 2.52B | 2.91B | 3.44B | 3.92B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 383.32M | 867.06M | 725.54M | 947.68M | 818.97M |
| Investing | -110.13M | -25.7M | -298.31M | -368.8M | -231.77M |
| Financing | -156.66M | -279.8M | -166.66M | -342.21M | -280.1M |
| Market Cap | 847.23M |
| Price to Earnings Ratio | 1.08 |
| Price to Sales Ratio | 0.33 |
| Price to Cash Ratio | 0.31 |
| Price to Book Ratio | 0.22 |
| Dividend Yield | - |
| Shares Outstanding | 811.99M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 1.0434 |
| 52 Week Low | 1.0434 |
| Spread (Intraday) | 41.56 (100%) |
| Company Name | Consun Pharmaceutical Group Ltd (PK) |
| Address |
windward 3 grand cayman KY 1-1108 |
| Website | https://www.chinaconsun.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
